Dissemination, communication, engagement and exploitation

Workpackage #9

Dissemination, communication, engagement and exploitation

WP9 will focus on communicating the iCARE4CVD’s progress and results to
everyone that can benefit from our novel research. By facilitating effective
patient-engagement and two-way communication, WP9 provides a
platform for the patient voice within iCARE4CVD.

Through collecting patient feedback and aiding dialogue between patients
and the project, WP9 ensures we follow a patient-centric approach.
Moreover, we will develop a strategic communication and dissemination
plan that delivers tailored messages to all other key target audiences the
project aims to connect with, such as industry, health care professionals,
regulatory authorities, researchers, and citizens. In doing so, WP9 lays the
foundation for future exploitation of project outputs such as the federated
database and novel decision tools.

Meet our team

Roche

Valérie N. Babinsky

Clinical Development Lead

Catalyze

Carolina Vieira

Team Lead & Senio Science Communication Advisor
Kirsten Budig

Novo Nordisk

Kirsten Budig

Senior Public Affairs Manager

Roche

Ina Meyer

Global Patient Partnership Leader

Roche

Markus Schwertfeger , Dr med.

Senior International Director Medical Affairs
Get updated

Our related news

2 July, 2026

More Data, Better Care? The Promise and Reality of Digital Biomarkers in Cardiovascular Disease

We have more data on our hearts than ever before. Smartwatches track..

29 June, 2026

Can AI make heart failure evidence reviews faster and more reliable? New iCARE4CVD research puts it to the test

Screening thousands of research papers is one of the most time-consuming steps..

1 June, 2026

Prediction or speculation: heart failure models for diabetes – An Editorial comment from iCARE4CVD

Can we predict heart failure in people with diabetes, or are we..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.